Seres Therapeutics, Inc. ( MCRB) - Key Metrics
MCRB Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.08 | $0.47 | -$2.32 | -$2.32 |
| 2026Q1 | $0.04 | -$2.08 | -$1.71 | -$1.71 |
| 2025Q4 | $0.05 | -$1.73 | -$1.66 | -$1.66 |
| 2025Q3 | $0.04 | $0.94 | $0.25 | $0.25 |
| 2025Q2 | $0 | -$2.27 | -$1.52 | -$1.54 |
MCRB Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 4.03 |
| 2026Q1 | 0% | -1.07 |
| 2025Q4 | 0% | -2.10 |
| 2025Q3 | 0% | 5.12 |
| 2025Q2 | 0% | -1.22 |
MCRB
Price: $4.34
52 week price:
Earnings Per Share: -2.42 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 536116
Ebitda: -5.4 millionMarket Capitalization: 48.9 million